Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Vital Chemtech Ltd

Vital Chemtech Ltd

Actions
  • Price (INR)74.40
  • Today's Change-0.600 / -0.80%
  • Shares traded4.80k
  • 1 Year change-23.30%
  • Beta--
Data delayed at least 15 minutes, as of Oct 31 2024 09:12 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vital Chemtech Limited is an India-based manufacturer of phosphorus derivatives. The Company is engaged in the business of manufacturing and supplying phosphorus derivatives, specialty chemicals, organic chemicals, heavy chemicals, and various intermediates for life sciences and crop protection. The Company's product portfolio includes Phosphorus Derivatives, Industrial Chemicals, Specialty Chemicals and Intermediates, Organophosphates, Polymers and Dispersants, and Wellness Products. Its Phosphorus Derivatives products include phosphorus trichloride (PCl3), phosphorus oxychloride (POCl3), phosphorus pentachloride (PCl5), phosphorus pentoxide (P2O5), poly phosphoric acid (PPA), and phosphorus pentasulfide (P2S5). The Company offers a range of wellness products in the form of tablets, capsules, oral powder and effervescent tablets for protein support, sugar control, support nutrition, cognitive health and mental health, and performance and fertility.

  • Revenue in INR (TTM)982.74m
  • Net income in INR-13.02m
  • Incorporated2021
  • Employees70.00
  • Location
    Vital Chemtech LtdOpp. Karnavati ClubS. G. Highway, B-406, Mondeal HeightAHMEDABAD 380015IndiaIND
  • Phone+91 7 946005840
  • Websitehttps://www.vitalgroup.co.in/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hindprakash Industries Ltd944.92m12.13m1.59bn45.00128.06--97.241.691.091.0985.55------------3.99--5.967.897.401.282.52--1.11--33.60-1.270.5824-37.01-11.34-43.62--
Sikko Industries Ltd625.78m53.29m1.63bn85.0030.57--26.672.603.173.1737.23--------7,362,106.00--6.73--13.1028.3028.858.525.94--7.41----23.3917.9140.5115.1511.53--
Ducol Organics & Colours Ltd754.05m44.29m1.72bn73.0038.912.7525.332.283.053.0551.8643.150.79842.376.8010,329,450.004.69--6.23--35.91--5.87--1.542.380.245---16.89---27.53------
Jocil Ltd8.11bn24.35m1.75bn768.0078.84--20.420.21542.492.49881.00--------10,556,860.00--3.60--4.4819.4513.760.30031.31--0.3009--23.71-18.0713.36-82.72-11.460.24438.45
Vital Chemtech Ltd982.74m-13.02m1.78bn70.00--2.11133.921.81-0.5568-0.556841.0335.210.71435.782.5414,039,110.00-0.9466---1.22--23.18---1.33--1.24-1.950.2341---15.82---116.18------
Arvee Laboratories (India) Ltd333.51m15.07m1.95bn65.00129.97--65.955.851.361.3630.16--------5,130,949.00--6.67--10.1248.2137.164.525.63--7.95-----50.54-11.18-74.46-14.2111.47--
Data as of Oct 31 2024. Currency figures normalised to Vital Chemtech Ltd's reporting currency: Indian Rupee INR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.